Schedule 13G ownership disclosure

DEPOMED INC

Security class unavailable · CUSIP: 249908104

Event date: 2016-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,322,753
Percent of class
3.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000914208-17-000060
Form type
SC 13G/A
Filer
Assertio Therapeutics, Inc
CIK
CIK 1005201
Filed
Feb 01, 2017
Reporting period
Dec 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub